Literature DB >> 18720264

Multiple sclerosis following etanercept treatment for ankylosing spondylitis.

C F Pfueller, E Seipelt, F Zipp, F Paul.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18720264     DOI： 10.1080/03009740802136164

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN： 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  15 in total

Review 1.  New-onset multiple sclerosis associated with adalimumab treatment in rheumatoid arthritis: a case report and literature review.

Authors:  Takumi Matsumoto; Ichiro Nakamura; Ayumi Miura; Gen Momoyama; Katsumi Ito
Journal:  Clin Rheumatol       Date:  2012-11-14       Impact factor: 2.980

Review 2.  Pulmonary, renal and neurological comorbidities in patients with ankylosing spondylitis; implications for clinical practice.

Authors:  Cecilia Mercieca; Irene E van der Horst-Bruinsma; Andrew A Borg
Journal:  Curr Rheumatol Rep       Date:  2014-08       Impact factor: 4.592

Review 3.  Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping.

Authors:  Ippazio Cosimo Antonazzo; Emanuel Raschi; Luca Vignatelli; Elisa Baldin; Trond Riise; Roberto D'Alessandro; Fabrizio De Ponti; Elisabetta Poluzzi
Journal:  Drug Saf       Date:  2017-09       Impact factor: 5.606

4.  Placenta suppresses experimental autoimmune hypophysitis through soluble TNF receptor 1.

Authors:  Melissa A Landek-Salgado; Noel R Rose; Patrizio Caturegli
Journal:  J Autoimmun       Date:  2011-07-23       Impact factor: 7.094

Review 5.  Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis.

Authors:  Sueli Carneiro; Penelope Esther Palominos; Sônia Maria Alvarenga Anti; Rodrigo Luppino Assad; Rafaela Silva Guimarães Gonçalves; Adriano Chiereghin; Andre Marun Lyrio; Antônio Carlos Ximenes; Carla Gonçalves Saad; Célio Roberto Gonçalves; Charles Lubianca Kohem; Cláudia Diniz Lopes Marques; Cláudia Goldenstein Schainberg; Eduardo de Souza Meirelles; Gustavo Gomes Resende; Lenise Brandao Pieruccetti; Mauro Waldemar Keiserman; Michel Alexandre Yazbek; Percival Degrava Sampaio-Barros; Ricardo da Cruz Lage; Rubens Bonfiglioli; Thauana Luíza Oliveira; Valderílio Feijó Azevedo; Washington Alves Bianchi; Wanderley Marques Bernardo; Ricardo Dos Santos Simões; Marcelo de Medeiros Pinheiro; Cristiano Barbosa Campanholo
Journal:  Adv Rheumatol       Date:  2021-11-24

Review 6.  Neurological disorders and inflammatory bowel diseases.

Authors:  Giovanni Casella; Gian Eugenio Tontini; Gabrio Bassotti; Luca Pastorelli; Vincenzo Villanacci; Luisa Spina; Vittorio Baldini; Maurizio Vecchi
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 7.  Differential diagnosis of white matter lesions: Nonvascular causes-Part II.

Authors:  S Weidauer; M Nichtweiss; E Hattingen
Journal:  Clin Neuroradiol       Date:  2014-02-12       Impact factor: 3.649

Review 8.  Structural brain lesions in inflammatory bowel disease.

Authors:  Can Dolapcioglu; Hatice Dolapcioglu
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

9.  Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature.

Authors:  E Andreadou; E Kemanetzoglou; Ch Brokalaki; M E Evangelopoulos; C Kilidireas; A Rombos; E Stamboulis
Journal:  Case Rep Neurol Med       Date:  2013-05-16

10.  Peculiar Cytological Cerebrospinal Fluid Pattern in a Case of Encephalomyelitis During Anti-Tumor Necrosis Factor-α Therapy.

Authors:  Yana Motuzova; Alessia Di Sapio; Marco Capobianco; Arianna Sala; Fabiana Marnetto; Simona Malucchi; Antonio Bertolotto
Journal:  Neurol Ther       Date:  2015-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.